Location History:
- Zurich, CH (2015 - 2022)
- Basel, CH (2023)
Company Filing History:
Years Active: 2015-2023
Title: Michael Honer: Innovator in Radiolabeled Compounds
Introduction
Michael Honer is a distinguished inventor based in Zurich, Switzerland. He has made significant contributions to the field of radiolabeled compounds, with a total of 5 patents to his name. His work focuses on innovative imaging tools that have the potential to advance medical diagnostics.
Latest Patents
Among his latest patents, one notable invention is related to radiolabeled compounds. This invention pertains to compounds of formula I, wherein specific components are labeled with a radionuclide selected from hydrogen, carbon, and fluorine. These compounds are designed for imaging alpha-synuclein and/or Abeta deposits in mammals, which is crucial for understanding neurodegenerative diseases. Another significant patent involves 2-hetaryl imidazol[1,2-a]pyridine derivatives. This invention relates to small molecule imaging tools, specifically compounds of formula II, and their pharmaceutically acceptable acid addition salts.
Career Highlights
Michael Honer is currently associated with Hoffmann-La Roche Inc., a leading company in the pharmaceutical industry. His work at the company has allowed him to push the boundaries of innovation in medical imaging and diagnostics.
Collaborations
Throughout his career, Michael has collaborated with notable colleagues, including Luca Claudio Gobbi and Edilio Borroni. These partnerships have fostered a collaborative environment that enhances the development of groundbreaking inventions.
Conclusion
Michael Honer is a prominent figure in the field of radiolabeled compounds, with a focus on advancing medical imaging technologies. His contributions are paving the way for improved diagnostic tools in healthcare.